Veklury remdesivir 100MG
Ended Awarded Last action
- Contract number
- 36C25621F0097
- Awardee
-
Gilead Sciences Inc. UEI FPJMGUK1BYH8
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $77,850
Award facts
- Contract value 100% obligated
- $77,850.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Foster City, CA 94404, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order under the GSA Schedule 61-IB for Pharmaceuticals and Drugs, awarded by the U.S. Department of Veterans Affairs (VA) to Gilead Sciences Inc. (Gilead) for the COVID-19 treatment Veklury (remdesivir). The $77,850 fixed-price contract has a performance period ending on March 31, 2021. Gilead, a large biopharmaceutical company, is the sole-source manufacturer of Veklury and a key supplier of critical medications to federal healthcare programs, particularly the VA. The contract was not set aside for small businesses. This award is part of Gilead's broader federal contract vehicles, including a $29.16 million Blanket Purchase Agreement with the VA National Acquisition Center for specialty medications, and a $33 million Federal Supply Schedule contract, which enable various agencies to efficiently procure Gilead's pharmaceutical portfolio.
Quick answers
Who was awarded contract 36C25621F0097?
36C25621F0097 was awarded to Gilead Sciences Inc. by Veterans Integrated Service Network 16 (Veterans Health Administration) on January 13, 2021.
How much is contract 36C25621F0097 worth?
The government has obligated $77,850 on 36C25621F0097.
Is contract 36C25621F0097 an order under another contract?
Yes. 36C25621F0097 is a delivery order under V797D70252, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25621F0097 competed?
The extent of competition for 36C25621F0097 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award